Order Description

Case Studies in Pathophysiology. Lippincott, Philadelphia, PA.

Bruyere – Case Study 12 & 14 Options Menu: Forum
Case study 12:

1. Do the patients arterial blood gas determinations indicate that the asthmatic attack is mild, moderate or bordering on respiratory failure ?

Case Study 14:

1. Would this patient benefit from home oxygen therapy ? If yes, how much would you anticipate and why?

CASE STUDY #9: PULMONARY THROMBOEMBOLISM Options Menu: Forum
1. IDENTIFY THIS PATIENT’S TWO MOST CRITICAL RISK FACTORS FOR PERIPHERL ARTERY DISEASE.

2. IDENTIFY FIVE MAJOR RISK FACTORS OF THIS PATIENT FOR PULMONARY THROMBOEMBOLISM ?

3. WHY DO YOU THINK THIS PATIENT IS TAKING AMITRIPTYLINE AT BED TIME EVERY EVENING ?

4. WHY IS THIS PATIENT TAKING METOCLOPRAMIDE?

5. WHAT CONDITION IS CAUSING CRAMPS IN THIS PATIENT FOR WHICH SHE REQUIRES IBUPROFEN?

CASE STUDY 3 :CONGESTIVE HEART FAILURE Options Menu: Forum
1. BASED ON THE LIMITED AMOUNT OF INFORMATION GIVEN ABOVE, DO YOU SUSPECT THAT THIS PATIENT HAS DEVELOPED LEFT-SIDED CHF, RIGHT-SIDE CHF OR TOTAL CHF?

2. hOW DID YOU ARRIVE AT YOUR ANSWER IN CHAPTER I

3.WHAT IS A LIKELY CAUSE OF THE PATIENT’S HEART FAILURE?

4, FROM THE INFORMATION GIVEN ABOVE, IDENTIFY THREE RISK FACTORS THAT PROBABLY CONTRIBUTRD TO THE PATIENT’S HEART ATTACK FIVE YEARS AGO.

5. WHAT IS THIS PATIENT TAKING ALLOPURINOL?

6. WHAT IS THIS PATIENT TAKING ATORVASTATIN ?

7, WHY IS THIS PATIENT TAING CELECOXIB?

8. WHI IS THIS PATIENT TAKING ASPIRIN AND CLOPIDOGREL<

9. WHAT CAN YOU SAY SAY ABOUT THIS PATIENT’S BLOOD PRESSURE ?

10. WHY MIGHT THIS PATIENT BE TACHYCARDIC?

11. WHY MIGHT THIS PATIENT BE TACHYPNEIC?

12. IS THIS PATIENT TECHNICALLY OVERWEIGHT, UNDERWEIGHT, OBESE OR IS HER WEIGHT HEALTHY ?

13. XPLAIN THE PATHOPHYSIOLOGY OF THE ABNORMAL SKIN MANIFESTATIONS

14. DO ABNORMAL FINDINGS IN THE NECK ( JVD AND HJR) SUGGEST LEFT HEART FAILURE, RIGHT HEART FAILURE OR TOTAL CHF.

15. WHICH ABNORMAL CARDIAC EXAM AND CHEST XRAY FINDINGS CLOSELY COMPLEMENT ONE ANOTHER ?

16. WHICH ABNORMAL CARDIAC EXAM AND ECG FINDINGS CLOSELY COMPLEMENT ONE ANOTHER .

17. WHY MIGHT THE ABNORMAL SERUM SODIUM AND POTASSIUM LEVELS SUGGEST.

18. EXPLAIN THE ABNORMAL BUN AND SERUM Cr CONCENTRATION .

19. WHAT MIGHT BE CAUSING THE ELEVATED SERUM GLUCOSE CONCENTRATIONS?

20. EXPLAIN THE ABNORMAL AST LEVEL.

21. EXPLAIN THE ABNORMAL ARTERIAL BLOOD GAS FINDINGS

22. WHICH HEMATOLOGICAL FINDINGS, IF ANY, ARE ABNORMAL?

23. IDENTIFY FOUR DRUGS THAT MIGHT BE IMMEDIATELY HELPFUL

24. WHAT DO THE TSH AND T4 DATA SUGGEST?

25. EJECTION FRACTION IS AN IMPORTANT CARDIAC FUNCTION PARAMETER THAT IS USED TO DETERMINE THE CONTRACTILE STATUS OF THE HEART AND IS MEASURED WITH SPECIALIZED TESTING PROCEDURES? IF A PATIENT HAS AN SV = 100 AND AN EDV = 200. IS EF ABNORMALLY HIGH, LOW OR NORMAL?

CASE STUDY 5: HYPERTENSION Options Menu: Forum
1. IDENTIFY SIX RISK FACTORS FOR HYPERTENSION IN THIS PATIENT?

2. WHY IS THIS PATIENT TAKING HYDROCHLOROTHIAZIDE? WHAT IS THE PRIMARY PHARMACOLOGIC MECHANISM OF ACTION OF THIS DRUG?

3. WHY IS THE PATIENT TAKING PSEUDOEPHEDRINE HYDROCHLORIDE AND WHAT IS THE MECHANISM OF ACTION OF THIS DRUG ?

4. WHY IS THE PATIENT TAKING BECLOMETHASONE AND WHAT IS THE MECHANISM OF ACTION.

5. WHAT IS THE MOST CLINICALLY SIGNIFICANT INFORMATION RELATED TO HTN IN THIS REVIEW OF SYSTEMS

6. IDENTIFY THE TWO MOST CLINICALY SIGNIFICANT VITAL SIGNS RELATIVE TO THIS PATIENT’S HTN?

7. WHAT IS THE SIGNIFICANCE OF HEENT EXAMINATION ?

8. WHICH ABNORMALITIES IN THE HEARY AND LUNG EXAMINATIONS MAY BE REALTED AND WHY MIGHT THESE CLINICAL SIGNS BE RELATED.

9. ARE THERE ANY ABNORMAL NEUROLOGIC FINDINGS AND, IF SO, MIGHT THEY BE CAUSED BY HTN?

10. WHU MIGHT THIS PATIENT’S GGT BE ABNORMAL?

11. IDENTIFY THREE OTHER CLINICALLY SIGNIFICANT LAB TEST ABOVE?

12. WHAT IS THE CLINICAL SIGNIFICANCE OF THE SINGLE ABNORMAL URINALYSIS FINDING?

13. WHAT IS THE LIKELY PATHOPHYSIOLOGIC MECHANISM FOR LVH IN THIS PATIENT?

14. WHAT DOES THE PATIENT’S EF SUGGEST ?